Fecal Recovery of Ingested Cellular DNA: Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms

Benjamin B. Strauss, Tracy C. Yab, Helen M. O’Connor, William R. Taylor, Douglas W. Mahoney, Julie A. Simonson, John Christensen, Suresh T Chari, David A. Ahlquist

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Stool DNA testing represents a potential noninvasive approach to detect upper gastrointestinal (UGI) neoplasms. However, little is known about fecal recovery efficiency of DNA exfoliated from UGI tumors. Aims: The purpose of this study was to establish a human ingestion model that quantitatively approximates daily cellular shedding from UGI neoplasms and to estimate fecal DNA marker recovery rates. Methods: Healthy volunteers (n = 10) ingested two scheduled doses of raw salmon, 0.3 and 30 g, simulating the mass exfoliated daily from 1 to 4.5 cm lesions. To approach a steady-state, each dose was ingested over three consecutive days in randomized order. Following defecation of an indicator dye ingested with test meals, stools were collected over 48 h. Ingested salmon DNA was captured from stools using probes targeting pathognomonic Salmonidae sequences (SlmII). Captured DNA was quantified using PCR primers to generate 178, 138, 88 and 55 bp amplicons. Results: SlmII sequences were recovered from all stools following salmon ingestion; recovery was proportional to amount ingested (p = 0.004). Fecal recovery of ingested salmon varied inversely with amplicon size targeted; mean recovery rates of SlmII were 0.49, 0.91, 3.63, and 7.31 copies per 100,000 copies ingested for 178, 134, 88, and 55 bp amplicons, respectively (p 

Original languageEnglish (US)
Pages (from-to)117-125
Number of pages9
JournalDigestive Diseases and Sciences
Volume61
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Gastrointestinal Neoplasms
Salmon
DNA
Eating
Salmonidae
Defecation
Genetic Markers
Meals
Healthy Volunteers
Coloring Agents
Polymerase Chain Reaction
Neoplasms

Keywords

  • Fecal DNA recovery
  • Noninvasive detection of upper gastrointestinal neoplasms
  • Simulated GI tumor exfoliation
  • Stool DNA testing

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Strauss, B. B., Yab, T. C., O’Connor, H. M., Taylor, W. R., Mahoney, D. W., Simonson, J. A., ... Ahlquist, D. A. (2016). Fecal Recovery of Ingested Cellular DNA: Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms. Digestive Diseases and Sciences, 61(1), 117-125. https://doi.org/10.1007/s10620-015-3845-z

Fecal Recovery of Ingested Cellular DNA : Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms. / Strauss, Benjamin B.; Yab, Tracy C.; O’Connor, Helen M.; Taylor, William R.; Mahoney, Douglas W.; Simonson, Julie A.; Christensen, John; Chari, Suresh T; Ahlquist, David A.

In: Digestive Diseases and Sciences, Vol. 61, No. 1, 01.01.2016, p. 117-125.

Research output: Contribution to journalArticle

Strauss, BB, Yab, TC, O’Connor, HM, Taylor, WR, Mahoney, DW, Simonson, JA, Christensen, J, Chari, ST & Ahlquist, DA 2016, 'Fecal Recovery of Ingested Cellular DNA: Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms', Digestive Diseases and Sciences, vol. 61, no. 1, pp. 117-125. https://doi.org/10.1007/s10620-015-3845-z
Strauss, Benjamin B. ; Yab, Tracy C. ; O’Connor, Helen M. ; Taylor, William R. ; Mahoney, Douglas W. ; Simonson, Julie A. ; Christensen, John ; Chari, Suresh T ; Ahlquist, David A. / Fecal Recovery of Ingested Cellular DNA : Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms. In: Digestive Diseases and Sciences. 2016 ; Vol. 61, No. 1. pp. 117-125.
@article{5e585f13d9fb48a9a89ece495780b4a0,
title = "Fecal Recovery of Ingested Cellular DNA: Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms",
abstract = "Background: Stool DNA testing represents a potential noninvasive approach to detect upper gastrointestinal (UGI) neoplasms. However, little is known about fecal recovery efficiency of DNA exfoliated from UGI tumors. Aims: The purpose of this study was to establish a human ingestion model that quantitatively approximates daily cellular shedding from UGI neoplasms and to estimate fecal DNA marker recovery rates. Methods: Healthy volunteers (n = 10) ingested two scheduled doses of raw salmon, 0.3 and 30 g, simulating the mass exfoliated daily from 1 to 4.5 cm lesions. To approach a steady-state, each dose was ingested over three consecutive days in randomized order. Following defecation of an indicator dye ingested with test meals, stools were collected over 48 h. Ingested salmon DNA was captured from stools using probes targeting pathognomonic Salmonidae sequences (SlmII). Captured DNA was quantified using PCR primers to generate 178, 138, 88 and 55 bp amplicons. Results: SlmII sequences were recovered from all stools following salmon ingestion; recovery was proportional to amount ingested (p = 0.004). Fecal recovery of ingested salmon varied inversely with amplicon size targeted; mean recovery rates of SlmII were 0.49, 0.91, 3.63, and 7.31 copies per 100,000 copies ingested for 178, 134, 88, and 55 bp amplicons, respectively (p ",
keywords = "Fecal DNA recovery, Noninvasive detection of upper gastrointestinal neoplasms, Simulated GI tumor exfoliation, Stool DNA testing",
author = "Strauss, {Benjamin B.} and Yab, {Tracy C.} and O’Connor, {Helen M.} and Taylor, {William R.} and Mahoney, {Douglas W.} and Simonson, {Julie A.} and John Christensen and Chari, {Suresh T} and Ahlquist, {David A.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/s10620-015-3845-z",
language = "English (US)",
volume = "61",
pages = "117--125",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Fecal Recovery of Ingested Cellular DNA

T2 - Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms

AU - Strauss, Benjamin B.

AU - Yab, Tracy C.

AU - O’Connor, Helen M.

AU - Taylor, William R.

AU - Mahoney, Douglas W.

AU - Simonson, Julie A.

AU - Christensen, John

AU - Chari, Suresh T

AU - Ahlquist, David A.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background: Stool DNA testing represents a potential noninvasive approach to detect upper gastrointestinal (UGI) neoplasms. However, little is known about fecal recovery efficiency of DNA exfoliated from UGI tumors. Aims: The purpose of this study was to establish a human ingestion model that quantitatively approximates daily cellular shedding from UGI neoplasms and to estimate fecal DNA marker recovery rates. Methods: Healthy volunteers (n = 10) ingested two scheduled doses of raw salmon, 0.3 and 30 g, simulating the mass exfoliated daily from 1 to 4.5 cm lesions. To approach a steady-state, each dose was ingested over three consecutive days in randomized order. Following defecation of an indicator dye ingested with test meals, stools were collected over 48 h. Ingested salmon DNA was captured from stools using probes targeting pathognomonic Salmonidae sequences (SlmII). Captured DNA was quantified using PCR primers to generate 178, 138, 88 and 55 bp amplicons. Results: SlmII sequences were recovered from all stools following salmon ingestion; recovery was proportional to amount ingested (p = 0.004). Fecal recovery of ingested salmon varied inversely with amplicon size targeted; mean recovery rates of SlmII were 0.49, 0.91, 3.63, and 7.31 copies per 100,000 copies ingested for 178, 134, 88, and 55 bp amplicons, respectively (p 

AB - Background: Stool DNA testing represents a potential noninvasive approach to detect upper gastrointestinal (UGI) neoplasms. However, little is known about fecal recovery efficiency of DNA exfoliated from UGI tumors. Aims: The purpose of this study was to establish a human ingestion model that quantitatively approximates daily cellular shedding from UGI neoplasms and to estimate fecal DNA marker recovery rates. Methods: Healthy volunteers (n = 10) ingested two scheduled doses of raw salmon, 0.3 and 30 g, simulating the mass exfoliated daily from 1 to 4.5 cm lesions. To approach a steady-state, each dose was ingested over three consecutive days in randomized order. Following defecation of an indicator dye ingested with test meals, stools were collected over 48 h. Ingested salmon DNA was captured from stools using probes targeting pathognomonic Salmonidae sequences (SlmII). Captured DNA was quantified using PCR primers to generate 178, 138, 88 and 55 bp amplicons. Results: SlmII sequences were recovered from all stools following salmon ingestion; recovery was proportional to amount ingested (p = 0.004). Fecal recovery of ingested salmon varied inversely with amplicon size targeted; mean recovery rates of SlmII were 0.49, 0.91, 3.63, and 7.31 copies per 100,000 copies ingested for 178, 134, 88, and 55 bp amplicons, respectively (p 

KW - Fecal DNA recovery

KW - Noninvasive detection of upper gastrointestinal neoplasms

KW - Simulated GI tumor exfoliation

KW - Stool DNA testing

UR - http://www.scopus.com/inward/record.url?scp=84952985279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952985279&partnerID=8YFLogxK

U2 - 10.1007/s10620-015-3845-z

DO - 10.1007/s10620-015-3845-z

M3 - Article

C2 - 26297132

AN - SCOPUS:84952985279

VL - 61

SP - 117

EP - 125

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 1

ER -